Shares of Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) reached a new 52-week high on Wednesday. The stock traded as high as $81.49 and last traded at $81.48, with a volume of 4,752 shares traded. The stock had previously closed at $79.31.
Lonza Group Price Performance
The company has a 50 day simple moving average of $70.96 and a 200-day simple moving average of $67.30. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.21 and a current ratio of 1.66.
Lonza Group Company Profile
Lonza Group AG is a Swiss contract development and manufacturing organization (CDMO) that supports pharmaceutical and biotechnology companies throughout the life cycle of their products. The company provides research, process development, testing, manufacturing, and regulatory support for therapies and other healthcare products, helping customers advance programs from early development through commercial production.
Lonza’s activities include the development and manufacture of biologics, small-molecule medicines, and cell and gene therapies.
Further Reading
- Five stocks we like better than Lonza Group
- Bloom Energy: The Off-Grid Answer to AI’s Power Drain
- Space Race 2.0: Intuitive Machines Secures Another NASA Contract
- Zebra Technologies’ Sell-Off: 3 Factors Investors May Be Missing
- Advanced Micro Devices’ Q3 Results Answer a Big Question, But Another Remains
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
